Skip to content
Home/Companies/Biotech/Algeta ASA

Algeta ASA

Biotech·Norway·Exited 2014·Held 9yr
Entry
2005
Hold
9yr
Exit
2014

Who owns Algeta ASA?

Algeta ASA was owned by HealthCap through HealthCap V (2005 vintage) from 2005 to 2014, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-18

HealthCap
Investor
HealthCap
HealthCap V · 2005 · VC

Key facts

HQNorway
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2014

More from HealthCap V

Other portfolio companies in the same fund.

CoreValve SA
Exited 2009
MedTechUS· 2007
to
Nexstim Oy
Exited 2014
MedTechFI· 2007
Bonesupport AB
Exited 2017
MedTechSweden· 2006
Alba Therapeutics Corp
Active
BiotechUS· 2005
Cerenis Therapeutics Holding SA
Exited 2015
BiotechFrance· 2005
Jerini AG
Exited 2008
BiotechGermany· 2005
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Algeta ASA

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Algeta ASA?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Algeta ASA.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue